govt.fyi
Back to HB 2365
Kansas Legislature· HB 2365Signed by Governor: Approved by Governor on Friday, April 10, 2026

Adding and removing certain substances in schedules I, III and IV of the uniform controlled substances act and making conforming changes to the criminal code definition of fentanyl-related controlled substances, the official text

Shown verbatim: the complete text as captured from the official page posted by the Kansas Legislature, fetched 2026-08-29. This is the enrolled version. The official bill page.
house bill No. 2365
An Act concerning controlled substances; adding and removing certain substances in schedule I, III and IV of the uniform controlled substances act; making conforming changes to the criminal code definition of fentanyl-related controlled substances; amending K.S.A. 65-4109 and K.S.A. 21-5701, 65-4105 and 65-4111 and repealing the existing sections.
Be it enacted by the Legislature of the State of Kansas:
Section 1. K.S.A. 2025 Supp. 21-5701 is hereby amended to read as follows: 21-5701. As used in K.S.A. 21-5701 through 21-5717, and amendments thereto:
(a) "Controlled substance" means any drug, substance or immediate precursor included in any of the schedules designated in K.S.A. 65-4105, 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.
(b) (1) "Controlled substance analog" means a substance that is intended for human consumption, and at least one of the following:
(A) The chemical structure of the substance is substantially similar to the chemical structure of a controlled substance listed in or added to the schedules designated in K.S.A. 65-4105 or 65-4107, and amendments thereto;
(B) the substance has a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant or hallucinogenic effect on the central nervous system of a controlled substance included in the schedules designated in K.S.A. 65-4105 or 65-4107, and amendments thereto; or
(C) with respect to a particular individual, such individual represents or intends the substance to have a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant or hallucinogenic effect on the central nervous system of a controlled substance included in the schedules designated in K.S.A. 65-4105 or 65-4107, and amendments thereto.
(2) "Controlled substance analog" does not include:
(A) A controlled substance;
(B) a substance for which there is an approved new drug application; or
(C) a substance with respect to which an exemption is in effect for investigational use by a particular person under section 505 of the federal food, drug, and cosmetic act, 21 U.S.C. § 355, to the extent conduct with respect to the substance is permitted by the exemption.
(c) "Cultivate" means the planting or promotion of growth of five or more plants that contain or can produce controlled substances.
(d) "Distribute" means the actual, constructive or attempted transfer from one person to another of some item whether or not there is an agency relationship. "Distribute" includes, but is not limited to, sale, offer for sale or any act that causes some item to be transferred from one person to another. "Distribute" does not include acts of administering, dispensing or prescribing a controlled substance as authorized by the pharmacy act of the state of Kansas, the uniform controlled substances act or otherwise authorized by law.
(e) (1) "Drug" means:
(A) Substances recognized as drugs in the official United States pharmacopeia, official homeopathic pharmacopoeia of the United States or official national formulary or any supplement to any of them;
(B) substances intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans or animals;
(C) substances, other than food, intended to affect the structure or any function of the body of humans or animals; and
(D) substances intended for use as a component of any article specified in subparagraph (A), (B) or (C).
(2) "Drug" does not include devices or their components, parts or accessories.
(f) (1) "Drug paraphernalia" means all equipment and materials of any kind that are used, or primarily intended or designed for use in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, testing, analyzing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling or otherwise introducing into the human body a controlled substance and in violation of this act.
(2) "Drug paraphernalia" includes, but is not limited to:
(A) Kits used or intended for use in planting, propagating, cultivating, growing or harvesting any species of plant that is a controlled substance or from which a controlled substance can be derived;
(B) kits used or intended for use in manufacturing, compounding, converting, producing, processing or preparing controlled substances;
(C) isomerization devices used or intended for use in increasing the potency of any species of plant that is a controlled substance;
(D) testing equipment used or intended for use in identifying or in analyzing the strength, effectiveness or purity of controlled substances;
(E) scales and balances used or intended for use in weighing or measuring controlled substances;
(F) diluents and adulterants, including, but not limited to, quinine hydrochloride, mannitol, mannite, dextrose and lactose that are used or intended for use in cutting controlled substances;
(G) separation gins and sifters used or intended for use in removing twigs and seeds from or otherwise cleaning or refining marijuana;
(H) blenders, bowls, containers, spoons and mixing devices used or intended for use in compounding controlled substances;
(I) capsules, balloons, envelopes, bags and other containers used or intended for use in packaging small quantities of controlled substances;
(J) containers and other objects used or intended for use in storing or concealing controlled substances;
(K) hypodermic syringes, needles and other objects used or intended for use in parenterally injecting controlled substances into the human body;
(L) objects used or primarily intended or designed for use in ingesting, inhaling or otherwise introducing marijuana, cocaine, hashish, hashish oil, phencyclidine (PCP), methamphetamine or amphetamine into the human body, such as:
(i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with or without screens, permanent screens, hashish heads or punctured metal bowls;
(ii) water pipes, bongs or smoking pipes designed to draw smoke through water or another cooling device;
(iii) carburetion pipes, glass or other heat-resistant tubes or any other device used, intended to be used or designed to be used to cause vaporization of a controlled substance for inhalation;
(iv) smoking and carburetion masks;
(v) roach clips, objects used to hold burning material, such as a marijuana cigarette, that has become too small or too short to be held in the hand;
(vi) miniature cocaine spoons and cocaine vials;
(vii) chamber smoking pipes;
(viii) carburetor smoking pipes;
(ix) electric smoking pipes;
(x) air-driven smoking pipes;
(xi) chillums;
(xii) bongs;
(xiii) ice pipes or chillers;
(xiv) any smoking pipe manufactured to disguise its intended purpose;
(xv) wired cigarette papers; or
(xvi) cocaine freebase kits.
(3) "Drug paraphernalia" does not include:
(A) Any products, chemicals or materials described in K.S.A. 21-5709(a), and amendments thereto; or
(B) any materials used or intended for use to test a substance for the presence of fentanyl, a fentanyl analog, ketamine or gamma hydroxybutyric acid.
(g) "Fentanyl-related controlled substance" means any substance designated in K.S.A. 65-4105(b)(1), (b)(2), (b)(4), (b)(10), (b)(11), (b)(12), (b)(15), (b)(16), (b)(17), (b)(20), (b)(21), (b)(24), (b)(26), (b)(27), (b)(28), (b)(35), (b)(42), (b)(43), (b)(44), (b)(45), (b)(48), (b)(50), (b)(54), (b)(55), (b)(56), (b)(57), (b)(58), (b)(59), (b)(68), (b)(70), (b)(71), (b)(72), (b)(73), (b)(74), (b)(75), (b)(76), (b)(77), (b)(78), (b)(79), (b)(80), (b)(81), (b)(82), (b)(83), (b)(84), (b)(85), (b)(91), (b)(97), (b)(98), (b)(99), (b)(103), (b)(104) (b)(66), (g)(1) or, (g)(2), (i) or 65-4107(c)(1), (c)(6), (c)(9), (c)(26), (c)(28), (c)(30), (f)(3)(A) or (f)(3)(B), and amendments thereto, or any analog thereof.
(h) "Immediate precursor" means a substance that the state board of pharmacy has found to be and by rules and regulations designates as being the principal compound commonly used or produced primarily for use and that is an immediate chemical intermediary used or likely to be used in the manufacture of a controlled substance, the control of which is necessary to prevent, curtail or limit manufacture.
(i) "Isomer" means all enantiomers and diastereomers.
(j) "Manufacture" means the production, preparation, propagation, compounding, conversion or processing of or placing into pill or capsule form a controlled substance either directly or indirectly or by extraction from substances of natural origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis. "Manufacture" does not include:
(1) The preparation or compounding of a controlled substance by an individual for the individual's own lawful use or the preparation, compounding, packaging or labeling of a controlled substance:
(A) By a practitioner or the practitioner's agent pursuant to a lawful order of a practitioner as an incident to the practitioner's administering or dispensing of a controlled substance in the course of the practitioner's professional practice; or
(B) by a practitioner or by the practitioner's authorized agent under such practitioner's supervision for the purpose of or as an incident to research, teaching or chemical analysis or by a pharmacist or medical care facility as an incident to dispensing of a controlled substance; or
(2) the addition of diluents or adulterants, including, but not limited to, quinine hydrochloride, mannitol, mannite, dextrose or lactose that are intended for use in cutting a controlled substance.
(k) "Marijuana" means all parts of all varieties of the plant Cannabis whether growing or not, the seeds thereof, the resin extracted from any part of the plant and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin. "Marijuana" does not include:
(1) The mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stalks, except the resin extracted therefrom, fiber, oil or cake or the sterilized seed of the plant that is incapable of germination;
(2) any substance listed in schedules II through V of the uniform controlled substances act;
(3) drug products approved by the United States food and drug administration as of the effective date of this act;
(4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
(5) industrial hemp as defined in K.S.A. 2-3901, and amendments thereto, when cultivated, produced, possessed or used for activities authorized by the commercial industrial hemp act.
(l) "Minor" means a person under 18 years of age.
(m) "Narcotic drug" means any of the following whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by a combination of extraction and chemical synthesis:
(1) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate;
(2) any salt, compound, isomer, derivative or preparation thereof that is chemically equivalent or identical with any of the substances referred to in paragraph (1) but not including the isoquinoline alkaloids of opium;
(3) opium poppy and poppy straw;
(4) coca leaves and any salt, compound, derivative or preparation of coca leaves and any salt, compound, isomer, derivative or preparation thereof that is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves that do not contain cocaine or ecgonine.
(n) "Opiate" means any substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having addiction-forming or addiction-sustaining liability. "Opiate" does not include, unless specifically designated as controlled under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). "Opiate" does include its racemic and levorotatory forms.
(o) "Opium poppy" means the plant of the species Papaver somniferum l. except its seeds.
(p) "Person" means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership, association or any other legal entity.
(q) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing.
(r) "School property" means property upon which is located a structure used by a unified school district or an accredited nonpublic school for student instruction or attendance or extracurricular activities of pupils enrolled in kindergarten or any of the grades one through 12. This definition shall not be construed as requiring that school be in session or that classes are actually being held at the time of the offense or that children must be present within the structure or on the property during the time of any alleged criminal act. If the structure or property meets the above definition, the actual use of that structure or property at the time alleged shall not be a defense to the crime charged or the sentence imposed.
(s) "Simulated controlled substance" means any product that identifies itself by a common name or slang term associated with a controlled substance and that indicates on its label or accompanying promotional material that the product simulates the effect of a controlled substance.
Sec. 2. K.S.A. 2025 Supp. 65-4105 is hereby amended to read as follows: 65-4105. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it.
(b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

1(1) Acetyl fentanyl
2(N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) 9821
3(2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
4piperidinyl]-N-phenylacetamide) 9815
5(3) Acetylmethadol 9601
6(4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
7phenylacrylamide;
8acryloylfentanyl) 9811
9(5)(2) AH-7921 (3,4-dichloro-N-[(1-
10dimethylamino)cyclohexylmethyl]benzamide) 9551
11(6)(3) Allylprodine 9602

1(7)(4) Alphacetylmethadol 9603
2(except levo-alphacetylmethadol also known as levo-alpha-
3acetylmethadol, levomethadyl acetate or LAAM)
4(8)(5) Alphameprodine 9604
5(9)(6) Alphamethadol 9605
6(10) Alpha′-methyl butyryl fentanyl (2-methyl-N-(1-
7phenethylpiperidin-4-yl)-N-phenylbutanamide) 9864
8(11) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-
9piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
10propanilido) piperidine) 9814
11(12) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
12piperidinyl]-N-phenylpropanamide) 9832
13(13)(7) Benzethidine 9606
14(14)(8) Betacetylmethadol 9607
15(15) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
16piperidinyl]-N-phenylpropanamide) 9830
17(16) Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2-
18phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) 9831
19(17) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-
20yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) 9836
21(18)(9) Betameprodine 9608
22(19)(10) Betamethadol 9609
23(20) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-
244-yl)propionamide; also known as β-methyl fentanyl) 9856
25(21) Beta'-phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N, 3-
26diphenylpropanamide; also known as β'-phenyl fentanyl; 3-
27phenylpropanoyl fentanyl) 9842
28(22)(11) Betaprodine 9611
29(23)(12) Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-
30dihydro-2H-benzo[d]imidazol-2-one) 9098
31(24)(13) Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1 H
32-benzimidazol-1-yl)- N,N -diethylethan-1-amine) 9751
33 Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
34phenylbutyramide) 9822
35(25)(14) Clonitazene 9612
36(26) Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-
37phenylbut-2-enamide) 9844
38(27) Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
39phenylcyclopentanecarboxamide) 9847
40(28) Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
41phenylcyclopropanecarboxamide) 9845
42(29)(15) Dextromoramide 9613
43(30)(16) Diampromide 9615
44(31)(17) Diethylthiambutene 9616
45(32)(18) Difenoxin 9168
46(33)(19) Dimenoxadol 9617
47(34)(20) Dimepheptanol 9618
48(35) 2′,5′-Dimethoxyfentanyl (N-(1-(2,5-
49dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide)
50 9861
51(36)(21) Dimethylthiambutene 9619
52(37)(22) Dioxaphetyl butyrate 9621
53(38)(23) Dipipanone 9622
54(39)(24) 2-(2-(4-ethoxybenzyl)-1 H -benzimidazol-1-yl)- N,N
55-diethylethan-1-amine (Other names: etodesnitazene; etazene)
56 9765
57(25) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1 H
58-benzimidazole (Other names: N -piperidinyl etonitazene;
59etonitazepipne) 9761
60(26) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H
61-benzimidazole (Other names: N -pyrrolidino etonitazene;
62etonitazepyne) 9758
63(27) Ethylmethylthiambutene 9623
64(40)(28) Etonitazene 9624

1(41)(29) Etoxeridine 9625
2(42) Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)
3(phenyl)carbamate) 9851
4(43) 2′-Fluoro ortho-fluorofentanyl (N-(1-(2-
5fluorophenethyl)piperidin-4-yl)-N-(2-
6fluorophenyl)propionamide; also known as 2′-fluoro 2-
7fluorofentanyl) 9855
8(44)(30) Flunitazene ( N,N -diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1 H
9-benzimidazol-1-yl)ethan-1-amine) 9756
10 Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-
112-carboxamide) 9834
12(45) 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
13phenylfuran-3-
14carboxamide) 9860
15(46)(31) Furethidine 9626
16(47)(32) 7-hydroxymitragynine (7-OH)
17(33) Hydroxypethidine 9627
18(48) Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
19phenylisobutyramide) 9827
20(49)(34) Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-
211H-benzimidazol-1-yl)ethan-1-amine; N,N-diethyl-2-[[4-(1-
22methylethoxy)phenyl]methyl]-5-nitro-1 H-benzimidazole-1-
23ethanamine) 9614
24(50) Isovaleryl fentanyl (3-methyl- N -(1-phenethylpiperidin-4-yl)-
25N-phenylbutanamide) 9862
26(51)(35) Ketobemidone 9628
27(52)(36) Levomoramide 9629
28(53)(37) Levophenacylmorphan 9631
29(54) Meta -Fluorofentanyl (N -(3-fluorophenyl)- N -(1-
30phenethylpiperidin-4-yl)propionamide) 9857
31(55) Meta -Fluoroisobutyryl fentanyl ( N -(3-fluorophenyl)- N -(1-
32phenethylpiperidin-4-yl)isobutyramide) 9858
33(56) Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-
34yl)-N-phenylacetamide) 9825
35(57)(38) 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1 H
36-benzimidazole (Other names: N -pyrrolidino metonitazene;
37metonitazepyne) 9762
38(39) 2-Methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-
39yl)piperazin-1-yl)
40 butan-1-one) 9664
414′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-
42phenylacetamide) 9819
43(58) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-
44N-
45phenylpropanamide) 9813
46(59) 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
47piperidinyl]-N-phenylpropanamide) 9833
48(60)(40) Metodesnitazene ( N,N -diethyl-2-(2-(4-methoxybenzyl)-1 H
49-benzimidazol-1-yl)ethan-1-amine) 9764
50(41) Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-
51benzimidazol-1-yl)ethan-1-amine) 9757
52(61)(42) Morpheridine 9632
53(62)(43) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) 9661
54(63)(44) MT-45 (1-cychohexyl-4-(1,2-diphenylethyl)piperazine) 9560
55(64)(45) N- ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1 H -benzimidazol-
561-yl)ethan-1-amine (Other name: N -desethyl isotonitazene) 9760
57(46) N,N -diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1 H -benzimidazol-
581-yl)ethan-1-amine (Other name: protonitazene) 9759
59(47) 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1 H
60-benzimidazole (Other names: N -pyrrolidino protonitazene;
61protonitazepyne) 9763
62(48) Noracymethadol 9633
63(65)(49) Norlevorphanol 9634
64(66)(50) Normethadone 9635

1(67)(51) Norpipanone 9636
2(68) Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-
3phenethylpiperidin-4-yl)
4acetamide) 9838
5(69)(52) O-desmethyltramadol (Some trade or other names: 2-
6((dimethylamino)methyl-1-(3-hydroxyphenyl)cyclohexanol;3-(2-
7((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol)
8(70) Ortho-fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-
9phenethylpiperidin-4-yl)acrylamide) 9852
10(71) Ortho-fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-
11phenethylpiperidin-4-yl)butyramide; also known as 2-
12fluorobutyryl fentanyl) 9846
13(72) Ortho-fluorofentanyl (N-(2-fluorophenyl)-N-(1-
14phenethylpiperidin-4-yl)propionamide; 2-fluorofentanyl) 9816
15(73) Ortho -Fluorofuranyl fentanyl ( N -(2-fluorophenyl)- N -(1-
16phenethylpiperidin-4-yl)furan-2-carboxamide) 9863
17(74) (Ortho-fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-
18phenethylpiperidin-4-yl)isobutyramide) 9853
19(75) Ortho-methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-
20phenethylpiperidin-4-yl)acetamide; also known as 2-methyl
21acetylfentanyl) 9848
22(76) Ortho-methyl methoxyacetyl fentanyl (2-methoxy-N-(2-
23methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also
24known as 2-methyl methoxyacetyl
25 fentanyl) 9820
26(77) Para-chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-
27phenethylpiperidin-4-yl)isobutyramide) 9826
28(78) Para-fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-
29phenethylpiperidin-4-yl)butyramide) 9823
30(79) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
31piperidinyl]propanamide) 9812
32(80) Para-fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-
33phenethylpiperidin-4-yl)isobutyramide, 4-fluoroisobutyryl
34fentanyl) 9824
35(81) Para-fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-
36phenethylpiperidin-4-yl)furan-2-carboxamide) 9854
37(82) Para-methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-
38phenethylpiperidin-4-yl)butyramide) 9837
39(83) Para -Methoxyfuranyl fentanyl ( N -(4-methoxyphenyl)- N -(1-
40phenethylpiperidin-4-yl)furan-2-carboxamide 9859
41(84) para -Methylcyclopropyl fentanyl ( N -(4-methylphenyl)- N -(1-
42phenethylpiperidin-4-yl)cyclopropanecarboxamide) 9865
43(85) Para-methylfentanyl (N-(4-methylphenyl)-N-(1-
44phenethylpiperidin-4-yl)propionamide; also known as 4-
45methylfentanyl) 9817
46(86)(53) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine) 9663
47(87)(54) Phenadoxone 9637
48(88)(55) Phenampromide 9638
49(89)(56) Phenomorphan 9647
50(90)(57) Phenoperidine 9641
51(91) Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
52phenylbenzamide; also known as benzoyl fentanyl) 9841
53(92)(58) Piritramide 9642
54(93)(59) Proheptazine 9643
55(94)(60) Properidine 9644
56(95)(61) Propiram 9649
57(96)(62) Racemoramide 9645
58(97) Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
59phenyltetrahydrofuran-2-carboxamide) 9843
60(98) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
61propanamide) 9835
62(99) Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
63phenylthiophene-2-carboxamide; also known as 2-thiofuranyl
64fentanyl; thiophene fentanyl) 9839

1(100)(63) Tilidine 9750
2(101)(64) Trimeperidine 9646
3(102)(65) U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-
4methylbenzamide) 9547
5(103) Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-
6phenylpentanamide) 9840
7(104)(66) Zipeprol (1-methoxy-3-[4-(2-methoxy-2-
8phenylethyl)piperazin-1-yl]-1-
9phenylpropan-2-ol) 9873(c) Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
14(1) Acetorphine 9319
15(2) Acetyldihydrocodeine 9051
16(3) Benzylmorphine 9052
17(4) Codeine methylbromide 9070
18(5) Codeine-N-Oxide 9053
19(6) Cyprenorphine 9054
20(7) Desomorphine 9055
21(8) Dihydromorphine 9145
22(9) Drotebanol 9335
23(10) Etorphine (except hydrochloride salt) 9056
24(11) Heroin 9200
25(12) Hydromorphinol 9301
26(13) Methyldesorphine 9302
27(14) Methyldihydromorphine 9304
28(15) Morphine methylbromide 9305
29(16) Morphine methylsulfonate 9306
30(17) Morphine-N-Oxide 9307
31(18) Myrophine 9308
32(19) Nicocodeine 9309
33(20) Nicomorphine 9312
34(21) Normorphine 9313
35(22) Pholcodine 9314
36(23) Thebacon 9315(d) Any material, compound, mixture or preparation that contains any quantity of the following hallucinogenic substances, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
42(1) Alpha-ethyltryptamine 7249
43Some trade or other names: etryptamine; Monase; α-ethyl-1H-
44indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET.
45(2) 4-bromo-2,5-dimethoxy-amphetamine 7391
46Some trade or other names: 4-bromo-2,5-dimethoxy-alpha-
47methylphenethylamine; 4-bromo-2,5-DMA.
48(3) 2,5-dimethoxyamphetamine 7396
49Some trade or other names: 2,5-dimethoxy-alpha-methyl-
50phenethylamine; 2,5-DMA.
51(4) 4-methoxyamphetamine 7411
52Some trade or other names: 4-methoxy-alpha-methylphene-
53thylamine; paramethoxyamphetamine; PMA.
54(5) 5-methoxy-3,4-methylenedioxy-amphetamine 7401
55(6) 4-methyl-2,5-dimethoxy-amphetamine 7395
56Some trade or other names: 4-methyl-2,5-dimethoxy-alpha-
57methylphenethylamine; "DOM"; and "STP".
58(7) 3,4-methylenedioxy amphetamine 7400
59(8) 3,4-methylenedioxymethamphetamine (MDMA) 7405
60(9) 3,4-methylenedioxy-N-ethylamphetamine (also known as N-
61ethyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, N-
62ethyl MDA, MDE, and MDEA) 7404
63(10) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-
64hydroxy-alpha-methyl-3,4-(methylenedioxy) phenethylamine,

1and N-hydroxy MDA) 7402
2(11) 3,4,5-trimethoxy amphetamine 7390
3(12) Bufotenine 7433
4Some trade or other names: 3-(Beta-Dimethylaminoethyl)-5-
5hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-
6dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine;
7mappine.
8(13) Diethyltryptamine 7434
9Some trade or other names: N,N-Diethyltryptamine; DET.
10(14) Dimethyltryptamine 7435
11Some trade or other names: DMT.
12(15) Ibogaine 7260
13Some trade or other names: 7-Ethyl-6,6 Beta,7,8,9,10,12,13-
14octahydro-2-methoxy-6,9-methano-5H-
15pyrido[1',2':1,2]azepino[5,4-b]indole; Tabernanthe iboga
16(16) Lysergic acid diethylamide 7315
17(17) Marijuana 7360
18(18) Mescaline 7381
19(19) Parahexyl 7374
20Some trade or other names: 3-Hexyl-l-hydroxy-7,8,9,10-
21tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl.
22(20) Peyote 7415
23Meaning all parts of the plant presently classified botanically as
24Lophophora williamsii Lemaire, whether growing or not, the
25seeds thereof, any extract from any part of such plant, and every
26compound, manufacture, salts, derivative, mixture or preparation
27of such plant, its seeds or extracts.
28(21) N-ethyl-3-piperidyl benzilate 7482
29(22) N-methyl-3-piperidyl benzilate 7484
30(23) Psilocybin 7437
31(24) Psilocyn 7438
32Some trade or other names: Psilocin.
33(25) Ethylamine analog of phencyclidine 7455
34Some trade or other names: N-ethyl-1-phenyl-cyclo-hexylamine;
35(1-phenylcyclohexyl)ethylamine; N-(1-
36phenylcyclohexyl)ethylamine; cyclohexamine; PCE.
37(26) Pyrrolidine analog of phencyclidine 7458
38Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine;
39PCPy; PHP.
40(27) Thiophene analog of phencyclidine 7470
41Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-
42piperidine; 2-thienyl analog of phencyclidine; TPCP; TCP.
43(28) 1-[1-(2-thienyl)-cyclohexyl] pyrrolidine 7473
44Some other names: TCPy.
45(29) 2,5-dimethoxy-4-ethylamphetamine 7399
46Some trade or other names: DOET.
47(30) Salvia divinorum or salvinorum A; all parts of the plant presently
48classified botanically as salvia divinorum, whether growing or
49not, the seeds thereof, any extract from any part of such plant,
50and every compound, manufacture, salts, derivative, mixture or
51preparation of such plant, its seeds or extracts.
52(31) Datura stramonium, commonly known as gypsum weed or
53jimson weed; all parts of the plant presently classified botanically
54as datura stramonium, whether growing or not, the seeds thereof,
55any extract from any part of such plant, and every compound,
56manufacture, salts, derivative, mixture or preparation of such
57plant, its seeds or extracts.
58(32) 1-(3-[trifluoromethylphenyl])piperazine
59Some trade or other names: TFMPP.
60(33) 4-Bromo-2,5-dimethoxyphenethylamine 7392
61(34) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its
62optical isomers, salts and salts of optical isomers 7348
63(35) Alpha-methyltryptamine (other name: AMT) 7432
64(36) 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its

1isomers, salts and salts of isomers 7439
2(37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) 7509
3(38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) 7508
4(39) 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) 7519
5(40) 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) 7518
6(41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) 7385
7(42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]
8ethanamine (2C-T-4) 7532
9(43) 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) 7517
10(44) 2-(2,5-Dimethoxy-4-nitrophenyl)ethanamine (2C-N) 7521
11(45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) 7524
12(46) 5–methoxy–N,N–dimethyltryptamine (5–MeO–DMT) 7431
13Some trade or other names: 5–methoxy–3–[2–(dimethylamino)
14ethyl]indole.
15(47) 2–(4–iodo–2,5–dimethoxyphenyl)–N–(2–
16methoxybenzyl)ethanamine 7538
17Some trade or other names: 25I–NBOMe; 2C–I–NBOMe; 25I;
18Cimbi–5.
19(48) 2–(4–chloro–2,5–dimethoxyphenyl)–N–(2–
20methoxybenzyl)ethanamine 7537
21Some trade or other names: 25C–NBOMe; 2C–C–NBOMe; 25C;
22Cimbi–82.
23(49) 2–(4–bromo–2,5–dimethoxyphenyl)–N–(2–
24methoxybenzyl)ethanamine 7536
25Some trade or other names: 25B–NBOMe; 2C–B–NBOMe; 25B;
26Cimbi–36.
27(50) 2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
28Some trade or other names: 25H-NBOMe.
29(51) 2-(2,5-dimethoxy-4-methylphenyl)-N-(2-
30methoxybenzyl)ethanamine
31Some trade or other names: 25D-NBOMe; 2C-D-NBOMe.
32(52) 2-(2,5-dimethoxy-4-nitrophenyl)-N-(2-
33methoxybenzyl)ethanamine
34Some trade or other names: 25N-NBOMe, 2C-N-NBOMe.
35(53) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-
36b]pyridine-3-carboxamide (5F-CUMYL-P7AICA) 7085
37(54) 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one (other
38names: methoxetamine, MXE) 7286
39(55) 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names:
40para-methoxymethamphetamine, PMMA) 1245(e) Any material, compound, mixture or preparation that contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
46(1) Etizolam 2780
47Some trade or other names: (4-(2-chlorophenyl)-2-ethyl-9-
48methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)
49(2) Mecloqualone 2572
50(3) Methaqualone 2565
51(4) Gamma hydroxybutyric acid 2010
52(5) 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]
53[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts
54of isomers
55 (other name: flualprazolam) 2785
56(6) 6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f]
57[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts
58of isomers (other name: clonazolam) 2786
59(7) 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f]
60[1,2,4]triazolo[4,3-a][1,4]diazepine, its salts, isomers, and salts
61of isomers
62 (other name: flubromazolam) 2788
63(8) 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e]
64[1,4]diazepin-2-one, its salts, isomers, and salts of isomers (other

1name: diclazepam) 2789(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:
7(1) Aminorex 1585
8Some other names: Aminoxaphen 2-amino-5-phenyl-2-oxazoline
9or 4,5-dihydro-5-phenyl-2-oxazolamine
10(2) Fenethylline 1503
11(3) N-ethylamphetamine 1475
12(4) (+)cis-4-methylaminorex ((+)cis-4,5-dihydro-4-methyl-5-phenyl-
132-oxazolamine) 1590
14(5) N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-
15benzeneethanamine; N,N-alpha-trimethylphenethylamine) 1480
16(6) Cathinone (some other names: 2-amino-1-phenol-1-propanone,
17alpha-amino propiophenone, 2-amino propiophenone and
18norphedrone) 1235
19(7) Substituted cathinones
20Any compound, except bupropion or compounds listed under a
21different schedule, structurally derived from 2–aminopropan–1–
22one by substitution at the 1-position with either phenyl, naphthyl,
23or thiophene ring systems, whether or not the compound is
24further modified in any of the following ways:
25 (A) By substitution in the ring system to any extent with alkyl,
26alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
27substituents, whether or not further substituted in the ring system
28by one or more other univalent substituents;
29 (B) by substitution at the 3-position with an acyclic alkyl
30substituent;
31 (C) by substitution at the 2-amino nitrogen atom with alkyl,
32dialkyl, benzyl, or methoxybenzyl groups; or
33 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
34structure.
35(8) N-benzylpiperazine (other names: BZP, 1-benzylpiprazine) 7493
36(9) Methiopropamine
37(N-methyl-1-(thiophen-2-yl)propan-2-amine) 1478
38(10) 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-
39methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-
404,5-dihydro-1,3-oxazol-2-amine) 1595
41(11) Amineptine (7-[(10,11-dihydro-5 H-dibenzo[a,d]cyclohepten-5-
42yl)
43amino]heptanoic acid) 1219
44(12) Mesocarb (N-phenyl-N ′-(3-(1-phenylpropan-2-yl)-1,2,3-
45oxadiazol-3-ium-5-yl)carbamimidate) 1227
46(13) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate) 1727(g) Any material, compound, mixture or preparation that contains any quantity of the following substances:
49(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
50(benzylfentanyl), its optical isomers, salts and salts of isomers
51(2) N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
52(thenylfentanyl), its optical isomers, salts and salts of isomers
53(3) Tianeptine, its optical isomers, salts and salts of isomers(h) Any of the following cannabinoids, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
58(1) Tetrahydrocannabinols 7370
59Meaning tetrahydrocannabinols naturally contained in a plant of
60the genus Cannabis (cannabis plant), as well as synthetic
61equivalents of the substances contained in the plant, or in the
62resinous extractives of Cannabis, sp. and/or synthetic substances,
63derivatives, and their isomers with similar chemical structure and
64pharmacological activity such as the following: Delta 1 9 cis or

1trans tetrahydrocannabinol, and their optical isomers Delta 6 8
2cis or trans tetrahydrocannabinol, and their optical isomers Delta
33,4 6a,10a cis or trans tetrahydrocannabinol, and its optical
4isomers (Since nomenclature of these substances is not
5internationally standardized, compounds of these structures,
6regardless of numerical designation of atomic positions
7covered.), except tetrahydrocannabinols in any of the following:(A) Industrial hemp, as defined in K.S.A. 2-3901, and amendments thereto;(B) solid waste, as defined in K.S.A. 65-3402, and amendments thereto, and hazardous waste, as defined in K.S.A. 65-3430, and amendments thereto, if such waste is the result of the cultivation, production or processing of industrial hemp, as defined in K.S.A. 2-3901, and amendments thereto, and such waste contains a delta-9 tetrahydrocannabinol concentration of not more than 0.3%; or(C) hemp products, as defined in K.S.A. 2-3901, and amendments thereto, unless otherwise deemed unlawful pursuant to K.S.A. 2-3908, and amendments thereto.For the purposes of this subsection, the dibenzopyran system is the numbering convention used to identify the carbon atoms of the chemical structure.
22(2) Naphthylmethylindoles
23Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane
24structure with substitution at the nitrogen atom of the indole
25group by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
26cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-
27piperidinyl)methyl or 2-(4-morpholinyl)ethyl group whether or
28not further substituted on the indole group to any extent and
29whether or not substituted on the benzyl or naphthyl ring to any
30extent.
31(3) Naphthoylpyrroles
32Any compound containing a 3-(1-naphthoyl)pyrrole structure
33with substitution at the nitrogen atom of the pyrrole group by an
34alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
35cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-
36(4-morpholinyl)ethyl group whether or not further substituted on
37the pyrrole group to any extent, whether or not substituted on the
38benzyl or naphthyl ring to any extent.
39(4) Naphthylmethylindenes
40Any compound containing a naphthylmethylindene structure
41with substitution at the 3-position of the indene group by an
42alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
43cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl or 2-
44(4-morpholinyl)ethyl group whether or not further substituted on
45the indene group to any extent, whether or not substituted on the
46benzyl or naphthyl ring to any extent.
47(5) Cyclohexylphenols
48Any compound containing a 2-(3-hydroxycyclohexyl)phenol
49structure with substitution at the 5-position of the phenolic ring
50by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
51cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-
52morpholinyl)ethyl group whether or not substituted on the
53cyclohexyl ring to any extent.
54(6) 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-
55de]-1,4-benzoxazin-6-yl]-1-napthalenylmethanone.
56Some trade or other names: WIN 55,212-2.
57(7) 9-(hydroxymethyl)-6, 6-dimethyl-3-(2-methyloctan-2-yl)-
586a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
59Some trade or other names: HU-210, HU-211.
60(8) Indole-3-carboxylate esters
61Any compound containing a 1H-indole-3-carboxylate ester
62structure with the ester oxygen bearing a naphthyl, quinolinyl,
63isoquinolinyl or adamantyl group and substitution at the 1
64position of the indole ring by an alkyl, haloalkyl, cyanoalkyl,

1alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-
22-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether
3or not further substituted on the indole ring to any extent and
4whether or not substituted on the naphthyl, quinolinyl,
5isoquinolinyl, adamantyl or benzyl groups to any extent.
6(9) Indazole-3-carboxamides
7Any compound containing a 1H-indazole-3-carboxamide
8structure with substitution at the nitrogen of the carboxamide by
9a naphthyl, quinolinyl, isoquinolinyl, adamantyl, benzyl, 1-
10amino-1-oxoalkan-2-yl or 1-alkoxy-1-oxoalkan-2-yl group and
11substitution at the 1 position of the indazole ring by an alkyl,
12haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
13cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-
14(4-morpholinyl)ethyl group, whether or not further substituted on
15the indazole ring to any extent and whether or not substituted on
16the naphthyl, quinolinyl, isoquinolinyl, adamantyl, 1-amino-1-
17oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl groups to any
18extent.
19(10) Indole-3-carboxamides
20Any compound containing a 1H-indole-3-carboxamide structure
21with substitution at the nitrogen of the carboxamide by a
22naphthyl, quinolinyl, isoquinolinyl, adamantyl, benzyl, 1-amino-
231-oxoalkan-2-yl or 1-alkoxy-1-oxoalkan-2-yl group and
24substitution at the 1 position of the indole ring by an alkyl,
25haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
26cycloalkylethyl, benzyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-
27(4-morpholinyl)ethyl group, whether or not further substituted on
28the indole ring to any extent and whether or not further
29substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl,
301-amino-1-oxoalkan-2-yl, 1-alkoxy-1-oxoalkan-2-yl or benzyl
31groups to any extent.
32(11) (1H-indazol-3-yl)methanones
33Any compound containing a (1H-indazol-3-yl)methanone
34structure with the carbonyl carbon bearing a naphthyl group and
35substitution at the 1 position of the indazole ring by an alkyl,
36haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, benzyl, 1-
37(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl
38group, whether or not further substituted on the indazole ring to
39any extent and whether or not substituted on the naphthyl or
40benzyl groups to any extent.
41(12) (1H-indol-3-yl)methanones
42Any compound containing a (1H-indol-3-yl)methanone structure
43with the carbonyl carbon bearing a naphthyl, quinolinyl,
44isoquinolinyl, adamantyl, phenyl, benzyl or
45tetramethylcyclopropyl group and substitution at the 1 position of
46the indole ring by an alkyl,haloalkyl, cyanoalkyl, alkenyl,
47cycloalkylmethyl, cycloalkylethyl, benzyl, 1-(N-methyl-2-
48piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-
49pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
50tetrahydropyranylmethyl group, whether or not further
51substituted on the indole ring to any extent and whether or not
52substituted on the naphthyl, quinolinyl, isoquinolinyl, adamantyl,
53phenyl, benzyl or tetramethylcyclopropyl groups to any extent.
54(13) Hexahydrocannabinol (HHC)
55(14) 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, its
56optical and geometric isomers, salts and salts of isomers (Some
57trade or ther names: CUMYL–PEGACLONE; SGT–151) 7093(i) (1) Unless specifically exempted or unless listed in schedules II through V of the uniform controlled substances act, any material, compound, mixture or preparation that contains any quantity of a fentanyl-related substance or that contains the salts, isomers and salts of isomers of a fentanyl-related substance whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation.(2) "Fentanyl-related substance" means any substance that is structurally related to fentanyl by one or more of the following modifications:(A) Replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle;(B) substitution in or on the phenethyl group (or replacement as described in sub-paragraph (A)) with alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino or nitro groups;(C) substitution in or on the piperidine ring with alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl, amino or nitro groups;(D) replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle; or(E) replacement of the N-propionyl group by another acyl group.Sec. 3. K.S.A. 65-4109 is hereby amended to read as follows: 65-4109. (a) The controlled substances listed in this section are included in schedule III and the number set forth opposite each drug or substance is the DEA controlled substances code which has been assigned to it.(b) Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system:

1(1) Any compound, mixture or preparation containing:
2(A) Amobarbital 2126
3(B) Secobarbital 2316
4(C) Pentobarbital 2271
5or any salt thereof and one or more other active medicinal
6ingredients which are not listed in any schedule.
7(2) Any suppository dosage form containing:
8(A) Amobarbital 2126
9(B) Secobarbital 2316
10(C) Pentobarbital 2271
11or any salt of any of these drugs and approved by the Food and
12Drug Administration for marketing only as a suppository.
13(3) Any substance which contains any quantity of a derivative of
14barbituric acid, or any salt of a derivative of barbituric acid,
15except those substances which are specifically listed in other
16schedules 2100
17(4) Chlorhexadol 2510
18(5) Lysergic acid 7300
19(6) Lysergic acid amide 7310
20(7) Methyprylon 2575
21(8) Sulfondiethylmethane 2600
22(9) Sulfonethylmethane 2605
23(10) Sulfonmethane 2610
24(11) Tiletamine and zolazepam or any salt thereof 7295
25Some trade or other names for a tiletamine-zolazepam
26combination product: Telazol
27Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-
28thienyl)-cyclohexanone
29Some trade or other names for zolazepam: 4-(2-fluorophenyl)-
306,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e][1,4]-diazepin-7(1H)-
31one, flupyrazapon
32(12) Ketamine, its salts, isomers, and salts of isomers 7285
33Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-
34(methylamino)-cyclohexanone
35(13) Gamma hydroxybutyric acid, any salt, hydroxybutyric
36compound, derivative or preparation of gamma hydroxybutyric
37acid contained in a drug product for which an application has
38been approved under section 505 of the federal food, drug and
39cosmetic act
40(14) Embutramide 2020
41(15) Perampanel, its salts, isomers, and salts of isomers 2261
42Some other names for perampanel: 2-(2-oxo-1-phenyl-5-pyridin-

12-yl-1,2 dihydropyridin-3-yl) benzonitrile
2(c) Nalorphine 9400(d) Any material, compound, mixture or preparation containing any of the following narcotic drugs or any salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
6(1) Not more than 1.8 grams of codeine or any of its salts per 100
7milliliters or not more than 90 milligrams per dosage unit with an
8equal or greater quantity of an isoquinoline alkaloid of opium
9 9803
10(2) not more than 1.8 grams of codeine or any of its salts per 100
11milliliters or not more than 90 milligrams per dosage unit with
12one or more active, nonnarcotic ingredients in recognized
13therapeutic amounts 9804
14(3) not more than 1.8 grams of dihydrocodeine or any of its salts per
15100 milliliters or not more than 90 milligrams per dosage unit
16with one or more active, nonnarcotic ingredients in recognized
17therapeutic amounts 9807
18(4) not more than 300 milligrams of ethylmorphine or any of its salts
19per 100 milliliters or not more than 15 milligrams per dosage unit
20with one or more active, nonnarcotic ingredients in recognized
21therapeutic amounts 9808
22(5) not more than 500 milligrams of opium per 100 milliliters or per
23100 grams or not more than 25 milligrams per dosage unit with
24one or more active, nonnarcotic ingredients in recognized
25therapeutic amounts 9809
26(6) not more than 50 milligrams of morphine or any of its salts per
27100 milliliters or per
28100 grams with one or more active, nonnarcotic ingredients in
29recognized therapeutic amounts 9810
30(7) any material, compound, mixture or preparation containing any
31of the following narcotic drugs or their salts, as set forth below:
32(A) Buprenorphine 9064(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
40(1) Those compounds, mixtures or preparations in dosage unit form
41containing any stimulant substance listed in schedule II, which
42compounds, mixtures or preparations were listed on August 25,
431971, as excepted compounds under section 308.32 of title 21 of
44the code of federal regulations, and any other drug of the
45quantitive composition shown in that list for those drugs or
46which is the same, except that it contains a lesser quantity of
47controlled substances 1405
48(2) Benzphetamine 1228
49(3) Chlorphentermine 1645
50(4) Chlortermine 1647
51(5) Phendimetrazine 1615
52 (f) Anabolic steroids 4000"Anabolic steroid" means any drug or hormonal substance, chemically and pharmacologically related to testosterone (other than estrogens, progestins, and corticosteroids) that promotes muscle growth, and includes:
57(1) 3β,17-dihydroxy-5a-androstane
58(2) 3α,17β-dihydroxy-5a-androstane
59(3) 5α-androstan-3,17-dione
60(4) 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene)
61(5) 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene)
62(6) 4-androstenediol (3β,17β-dihydroxy-androst-4-ene)
63(7) 5-androstenediol (3β,17β-dihydroxy-androst-5-ene)
64(8) 1-androstenedione ([5α]-androst-1-en-3,17-dione)

1(9) 4-androstenedione (androst-4-en-3,17-dione)
2(10) 5-androstenedione (androst-5-en-3,17-dione)
3(11) bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)
4(12) boldenone (17β-hydroxyandrost-1,4-diene-3-one)
5(13) boldione (androsta-1,4-diene-3,17-dione)
6(14) calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one)
7(15) clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one)
8(16) dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-
9methyl-androst-1,4-dien-3-one)
10(17) desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol)
11(also known as "madol")
12(18) Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en-3-one)
13(also known as "1-testosterone")
14(19) 4-dihydrotestosterone (17β-hydroxy-androstan-3-one)
15(20) drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one)
16(21) ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene)
17(22) fluoxymesterone (9-fluoro-17α-methyl-11β,17β-
18dihydroxyandrost-4-en-3-one)
19(23) formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-
201,4-dien-3-one)
21(24) furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-furazan)
22(25) 13β-ethyl-17β-hydroxygon-4-en-3-one
23(26) 4-hydroxytestosterone (4,17β-dihydroxy-androst-4-en-3-one)
24(27) 4-hydroxy-19-nortestosterone (4,17β-dihydroxy-estr-4-en-3-one)
25(28) mestanolone (17α-methyl-17β-hydroxy-5-androstan-3-one)
26(29) mesterolone (1α-methyl-17β-hydroxy-[5α]-androstan-3-one)
27(30) methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-
28one)
29(31) methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene)
30(32) methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one)
31(33) methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one)
32(34) 17α-methyl-3β,17β-dihydroxy-5a-androstane
33(35) 17α-methyl-3α,17β-dihydroxy-5a-androstane
34(36) 17α-methyl-3β,17β-dihydroxyandrost-4-ene
35(37) 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-
36hydroxyestr-4-en-3-one)
37(38) methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-
38one)
39(39) methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-
40one)
41(40) methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one)
42(41) mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one)
43(42) 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-
445α-androst-1-en-3-one) (also known as "17-α-methyl-1-
45testosterone")
46(43) nandrolone (17β-hydroxyestr-4-en-3-one)
47(44) 19-nor-4-androstenediol (3β, 17β-dihydroxyestr-4-ene)
48(45) 19-nor-4-androstenediol (3α, 17β-dihydroxyestr-4-ene)
49(46) 19-nor-5-androstenediol (3β, 17β-dihydroxyestr-5-ene)
50(47) 19-nor-5-androstenediol (3α, 17β-dihydroxyestr-5-ene)
51(48) 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-
52dione)
53(49) 19-nor-4-androstenedione (estr-4-en-3,17-dione)
54(50) 19-nor-5-androstenedione (estr-5-en-3,17-dione)
55(51) norbolethone (13β, 17α-diethyl-17β-hydroxygon-4-en-3-one)
56(52) norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one)
57(53) norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one)
58(54) normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one)
59(55) oxandrolone (17α-methyl-17β-hydroxy-2-oxa-[5α]-androstan-3-
60one)
61(56) oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one)
62(57) oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy-
63[5α]-androstan-3-one)
64(58) prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole)

1(59) stanozolol (17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]-
2pyrazole)
3(60) stenbolone (17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one)
4(61) testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-
5oic acid lactone)
6(62) testosterone (17β-hydroxyandrost-4-en-3-one)
7(63) tetrahydrogestrinone (13β, 17α-diethyl-17β-hydroxygon-4,9,11-
8trien-3-one)
9(64) trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
10(65) 5α-androstan-3,6,17-trione;
11(66) 6-bromo-androsta-1,4-diene-3,17-dione;
12(67) 6-bromo-androstan-3,17-dione;
13(68) 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol;
14(69) 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol;
15(70) 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one;
16(71) 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione;
17(72) 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one;
18(73) 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol;
19(74) estra-4,9,11-triene-3,17-dione;
20(75) [3,2-c]furazan-5α-androstan-17β-ol;
21(76) 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one;
22(77) 4-hydroxy-androst-4-ene-3,17-dione;
23(78) 17β-hydroxy-androstano[2,3-d]isoxazole;
24(79) 17β-hydroxy-androstano[3,2-c]isoxazole;
25(80) 3β-hydroxy-estra-4,9,11-triene-17-one;
26(81) 17α-methyl-androsta-1,4-diene-3,17β-diol;
27(82) 17α-methyl-5α-androstan-17β-ol;
28(83) 17α-methyl-androstan-3-hydroxyimine-17β-ol;
29(84) 6α-methyl-androst-4-ene-3,17-dione;
30(85) 17α-methyl-androst-2-ene-3,17β-diol;
31(86) [3,2-c]pyrazole-androst-4-en-17β-ol;
32(87) any salt, ester, or isomer of a drug or substance described or
33listed in this paragraph, if that salt, ester, or isomer promotes
34muscle growth.(A) Except as provided in (B), such term does not include an anabolic steroid which is expressly intended for administration through implants to cattle or other nonhuman species and which has been approved by the United States' secretary of health and human services for such administration.(B) If any person prescribes, dispenses or distributes such steroid for human use, such person shall be considered to have prescribed, dispensed or distributed an anabolic steroid within the meaning of this subsection (f).(g) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substance, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:
49(1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft
50gelatin capsule in a United States food and drug administration
51approved product 7369
52Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-
53tetrahydro-6-6-9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-0l,
54or (-)-delta-9-(trans)-tetrahydrocannabinol.(h) The board may except by rule any compound, mixture or preparation containing any stimulant or depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.Sec. 4. K.S.A. 2025 Supp. 65-4111 is hereby amended to read as follows: 65-4111. (a) The controlled substances listed in this section are included in schedule IV and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it.(b) Any material, compound, mixture or preparation that contains any quantity of the following substances including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation and having a potential for abuse associated with a depressant effect on the central nervous system:

1(1) Alprazolam 2882
2(2) Barbital 2145
3(3) Brexanolone 2400
4(4) Bromazepam 2748
5(5) Camazepam 2749
6(6) Carisoprodol 8192
7(7) Chloral betaine 2460
8(8) Chloral hydrate 2465
9(9) Chlordiazepoxide 2744
10(10) Clobazam 2751
11(11) Clonazepam 2737
12(12) Clorazepate 2768
13(13) Clotiazepam 2752
14(14) Cloxazolam 2753
15(15) Daridorexant 2410
16(16) Delorazepam 2754
17(17) Diazepam 2765
18(18) Dichloralphenazone 2467
19(19) Estazolam 2756
20(20) Ethchlorvynol 2540
21(21) Ethinamate 2545
22(22) Ethyl loflazepate 2758
23(23) Fludiazepam 2759
24(24) Flunitrazepam 2763
25(25) Flurazepam 2767
26(26) Fospropofol 2138
27(27) Halazepam 2762
28(28) Haloxazolam 2771
29(29) Ketazolam 2772
30(30) Lemborexant 2245
31(31) Loprazolam 2773
32(32) Lorazepam 2885
33(33) Lormetazepam 2774
34(34) Mebutamate 2800
35(35) Medazepam 2836
36(36) Meprobamate 2820
37(37) Methohexital 2264
38(38) Methylphenobarbital (mephobarbital) 2250
39(39) Midazolam 2884
40(40) Nimetazepam 2837
41(41) Nitrazepam 2834
42(42) Nordiazepam 2838
43(43) Oxazepam 2835
44(44) Oxazolam 2839
45(45) Paraldehyde 2585
46(46) Petrichloral 2591
47(47) Phenobarbital 2285
48(48) Pinazepam 2883
49(49) Prazepam 2764
50(50) Quazepam 2881
51(51) Remimazolam 2846
52(52) Temazepam 2925
53(53) Tetrazepam 2886
54(54) Triazolam 2887

1(55) Zolpidem 2783
2(56) Zaleplon 2781
3(57) Zopiclone 2784
4(58) Alfaxalone. 2731
5(59) Suvorexant 2223
6(60) Zuranolone 2420(c) Any material, compound, mixture or preparation that contains any quantity of lorcaserin (1625), including its salts, isomers and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible (21 U.S.C. § 812; 21 C.F.R. § 1308.14).(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
18(1) Cathine ((+)-norpseudoephedrine) 1230
19(2) Diethylpropion 1610
20(3) Fencamfamin 1760
21(4) Fenproporex 1575
22(5) Mazindol 1605
23(6) Mefenorex 1580
24(7) Pemoline (including organometallic complexes and chelates
25thereof) 1530
26(8) Phentermine 1640
27The provisions of subsection (d)(8) shall expire on the date
28phentermine and its salts and isomers are removed from
29schedule IV of the federal controlled substances act (21
30U.S.C. § 812; 21 C.F.R. § 1308.14).
31(9) Pipradrol 1750
32(10) Serdexmethylphenidate 1729
33(11) SPA((-)-1-dimethylamino-1, 2-diphenylethane) 1635
34(12) Sibutramine 1675
35(13) Solriamfetol (2-amino-3-phenylpropyl carbamate;
36benzenepropanol, beta-amino-, carbamate (ester)) 1650
37(14) MondafinilModafinil 1680(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following, including salts thereof:
41(1) Pentazocine 9709
42(2) Butorphanol (including its optical isomers) 9720
43(3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-
44dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-
452-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including
46its optical isomers) and its salts, isomers, and salts
47 of isomers 9725(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
52(1) Not more than 1 milligram of difenoxin and not less than 25
53micrograms of atropine sulfate per dosage unit 9167
54(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-
55diphenyl-3-methyl-2-propion-oxybutane) 9278
56(3) 2-[(dimethylamino)methyl]-1-(3-
57methoxyphenyl)cyclohexanol, its salts, optical and geometric
58isomers and salts of these isomers (including tramadol) 9752(g) Butyl nitrite and its salts, isomers, esters, ethers or their salts.(h) The board may except by rule and regulation any compound, mixture or preparation containing any depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.Sec. 5 K.S.A. 65-4109 and K.S.A 2025 Supp. 21-5701, 65-4105 and 65-4111 are hereby repealed.Sec. 6. This act shall take effect and be in force from and after its publication in the statute book.I hereby certify that the above Bill originated in the House, and was adopted by that body House adoptedConference Committee Report Speaker of the House. Chief Clerk of the House. Passed the Senate as amended Senate adoptedConference Committee Report President of the Senate. Secretary of the Senate. Approved Governor.
Every fact on this page links to its source, starting with the official bill record.